Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The enhancement of Moloney murine sarcoma virus (M-MuSV) tumor growth in BALB/c mice previously infected with lactate dehydrogenase virus (LDV) was shown to depend on the timing of the inoculations. Mice infected with LDV either 3 or 4 days prior to the M-MuSV inoculations demonstrated enhanced tumor growth, whereas mice infected simultaneously with LDV and M-MuSV or with LDV 30 days prior to M-MuSV challenge did not demonstrate M-MuSV tumor enhancement. Circulating immune complexes (CIC) were isolated from serum pools of LDV-infected mice. IgM-containing CIC were isolated only between 3 and 9 days post LDV infection. CIC containing IgG1 were isolated only between days 6 and 13, whereas IgG2-containing CIC were not detected until 18 days post LDV infection. Coincubation of isolated immune complexes (IC) with M-MuSV-sensitized cytotoxic lymphocyte-transformed and M-MuSV-transformed target cells produced a 56% reduction in M-MuSV-specific cytotoxicity, with LDV-antibody IC isolated from the sera of mice 11 days post LDV infection. CIC isolated from the sera of mice 5 days and 25 days after infection with LDV demonstrated 11 and 9% reductions in M-MuSV cytotoxicity, respectively. LDV-antibody IC composed of IgG1 antibody may act as blocking factors to M-MuSV-sensitized lymphocytes in vitro and may be responsible for the transient M-MuSV tumor enhancement observed in dually infected mice.

Original languageEnglish (US)
Pages (from-to)493-497
Number of pages5
JournalJournal of the National Cancer Institute
Volume70
Issue number3
StatePublished - Jan 1 1983

Fingerprint

Lactate dehydrogenase-elevating virus
Moloney murine sarcoma virus
Cellular Immunity
Antigen-Antibody Complex
Antibodies
Virus Diseases
Immunoglobulin G
Neoplasms
Serum
Lymphocytes
Growth

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{617afa495c2a4d4598216997966e05be,
title = "Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex",
abstract = "The enhancement of Moloney murine sarcoma virus (M-MuSV) tumor growth in BALB/c mice previously infected with lactate dehydrogenase virus (LDV) was shown to depend on the timing of the inoculations. Mice infected with LDV either 3 or 4 days prior to the M-MuSV inoculations demonstrated enhanced tumor growth, whereas mice infected simultaneously with LDV and M-MuSV or with LDV 30 days prior to M-MuSV challenge did not demonstrate M-MuSV tumor enhancement. Circulating immune complexes (CIC) were isolated from serum pools of LDV-infected mice. IgM-containing CIC were isolated only between 3 and 9 days post LDV infection. CIC containing IgG1 were isolated only between days 6 and 13, whereas IgG2-containing CIC were not detected until 18 days post LDV infection. Coincubation of isolated immune complexes (IC) with M-MuSV-sensitized cytotoxic lymphocyte-transformed and M-MuSV-transformed target cells produced a 56{\%} reduction in M-MuSV-specific cytotoxicity, with LDV-antibody IC isolated from the sera of mice 11 days post LDV infection. CIC isolated from the sera of mice 5 days and 25 days after infection with LDV demonstrated 11 and 9{\%} reductions in M-MuSV cytotoxicity, respectively. LDV-antibody IC composed of IgG1 antibody may act as blocking factors to M-MuSV-sensitized lymphocytes in vitro and may be responsible for the transient M-MuSV tumor enhancement observed in dually infected mice.",
author = "McDonald, {T. L.}",
year = "1983",
month = "1",
day = "1",
language = "English (US)",
volume = "70",
pages = "493--497",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex

AU - McDonald, T. L.

PY - 1983/1/1

Y1 - 1983/1/1

N2 - The enhancement of Moloney murine sarcoma virus (M-MuSV) tumor growth in BALB/c mice previously infected with lactate dehydrogenase virus (LDV) was shown to depend on the timing of the inoculations. Mice infected with LDV either 3 or 4 days prior to the M-MuSV inoculations demonstrated enhanced tumor growth, whereas mice infected simultaneously with LDV and M-MuSV or with LDV 30 days prior to M-MuSV challenge did not demonstrate M-MuSV tumor enhancement. Circulating immune complexes (CIC) were isolated from serum pools of LDV-infected mice. IgM-containing CIC were isolated only between 3 and 9 days post LDV infection. CIC containing IgG1 were isolated only between days 6 and 13, whereas IgG2-containing CIC were not detected until 18 days post LDV infection. Coincubation of isolated immune complexes (IC) with M-MuSV-sensitized cytotoxic lymphocyte-transformed and M-MuSV-transformed target cells produced a 56% reduction in M-MuSV-specific cytotoxicity, with LDV-antibody IC isolated from the sera of mice 11 days post LDV infection. CIC isolated from the sera of mice 5 days and 25 days after infection with LDV demonstrated 11 and 9% reductions in M-MuSV cytotoxicity, respectively. LDV-antibody IC composed of IgG1 antibody may act as blocking factors to M-MuSV-sensitized lymphocytes in vitro and may be responsible for the transient M-MuSV tumor enhancement observed in dually infected mice.

AB - The enhancement of Moloney murine sarcoma virus (M-MuSV) tumor growth in BALB/c mice previously infected with lactate dehydrogenase virus (LDV) was shown to depend on the timing of the inoculations. Mice infected with LDV either 3 or 4 days prior to the M-MuSV inoculations demonstrated enhanced tumor growth, whereas mice infected simultaneously with LDV and M-MuSV or with LDV 30 days prior to M-MuSV challenge did not demonstrate M-MuSV tumor enhancement. Circulating immune complexes (CIC) were isolated from serum pools of LDV-infected mice. IgM-containing CIC were isolated only between 3 and 9 days post LDV infection. CIC containing IgG1 were isolated only between days 6 and 13, whereas IgG2-containing CIC were not detected until 18 days post LDV infection. Coincubation of isolated immune complexes (IC) with M-MuSV-sensitized cytotoxic lymphocyte-transformed and M-MuSV-transformed target cells produced a 56% reduction in M-MuSV-specific cytotoxicity, with LDV-antibody IC isolated from the sera of mice 11 days post LDV infection. CIC isolated from the sera of mice 5 days and 25 days after infection with LDV demonstrated 11 and 9% reductions in M-MuSV cytotoxicity, respectively. LDV-antibody IC composed of IgG1 antibody may act as blocking factors to M-MuSV-sensitized lymphocytes in vitro and may be responsible for the transient M-MuSV tumor enhancement observed in dually infected mice.

UR - http://www.scopus.com/inward/record.url?scp=0020560131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020560131&partnerID=8YFLogxK

M3 - Article

C2 - 6572738

AN - SCOPUS:0020560131

VL - 70

SP - 493

EP - 497

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 3

ER -